Elevated DDR1 expression has also been reported in: (i) 52.2 % of hepatocellular carcinoma samples [11]; (ii) 61.0 % of non-small cell lung cancer [21]; and (iii) 63 % of serous ovarian cancer tissues [13]. This evidence concerns the gene DDR1 and hepatocellular carcinoma.